|
US 12,215,106 B2 |
|
| Pharmaceutical compounds and therapeutic methods |
| David J. Augeri, New Brunswick, NJ (US); Hatim Sabaawy, New Brunswick, NJ (US); and John A. Gilleran, New Brunswick, NJ (US) |
| Assigned to RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, New Brunswick, NJ (US) |
| Appl. No. 17/297,397 |
| Filed by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, New Brunswick, NJ (US) |
PCT Filed Nov. 26, 2019, PCT No. PCT/US2019/063356
§ 371(c)(1), (2) Date May 26, 2021,
PCT Pub. No. WO2020/112845, PCT Pub. Date Jun. 4, 2020. |
| Claims priority of provisional application 62/771,956, filed on Nov. 27, 2018. |
| Prior Publication US 2022/0002296 A1, Jan. 6, 2022 |
| Int. Cl. C07D 471/04 (2006.01); A61P 35/00 (2006.01) |
